Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

70 results about "Cytotoxicity testing" patented technology

Cytotoxicity tests are designed to determine the toxicity to cells of compounds either qualitatively or quantitatively. Qualitative cytotoxicity tests offered by Pacific BioLabs are the Direct Contact Test, the Indirect Contact Agar Diffusion Test, and the MEM Elution Test.

Method for testing cytotoxicity in full smoke contamination of cigarette

ActiveCN102140489ASolve the shortcomings of not being able to fully experience the full smoke of cigarettesReduce fixation stepsMicrobiological testing/measurementBiotechnologyPetri dish
The invention relates to a method for testing cytotoxicity in full smoke contamination of cigarette. In the method, when full smoke exposure of the cigarette is carried out, an insertion type cell culture dish is used so that cultured cells are positioned at a gas-liquid interface between the smoke and the culture solution, and therefore, the purpose that the cells directly and fully contact withcigarette smoke is achieved, and the feel of the cells to the cigarette smoke can be comprehensively reflected. The method has high sensitivity, and the result can more truly reflect the cytotoxicityof the cigarette smoke. The insertion type cell culture dish is used so that a grain-phase part and a gas-phase part in the main-flow smoke of the cigarette directly and fully contact with the cultured cells, and when the full smoke exposure of the cigarette is carried out, the cells growing at microporous membrane attached to a wall are positioned at the gas-liquid interface between the cigarette smoke and the exposed culture solution, so that the problem that the cells can not comprehensively feel the full cigarette smoke in the previous experiments is solved; and meanwhile, in the method, the stationary step for formaldehyde stationary liquid is reduced so that the experimental process is simpler and more convenient.
Owner:ZHENGZHOU TOBACCO RES INST OF CNTC

In-vitro cytotoxicity testing device for anesthesia breathing pipeline and working method of in-vitro cytotoxicity testing device

The invention discloses an in-vitro cytotoxicity testing device for an anesthesia breathing pipeline and a working method of the in-vitro cytotoxicity testing device, and belongs to the technical field of medical instrument inspection. The testing device comprises a gas power control device, an in-vitro artificial lung breathing system and gas condensate water collecting equipment, wherein the gaspower control device comprises a cylinder for simulating breathing movement; the in-vitro artificial lung breathing system comprises a gas storage container; a gas bag is arranged in the gas storagecontainer; an airtight water seal device is arranged below the gas storage container; the in-vitro artificial lung breathing system is positioned in a heat insulation box body; and the gas condensatewater collecting equipment comprises a condensing pipe and a condensate liquid collecting bottle. According to the technical scheme of the embodiment of the invention, the cytotoxicity index of the gas pipeline is tested by simulating clinical actual use condition, the collected gas condensate liquid can be used for other biocompatibility testing requirements, and the biocompatibility testing problem of gas pipeline type medical instruments for anesthesia breathing is fundamentally solved.
Owner:山东省医疗器械产品质量检验中心

Method for evaluating leaching toxicity of municipal waste incineration fly ash

The invention discloses a method for evaluating leaching toxicity of municipal waste incineration fly ash. The method comprises the following steps: S1, preparing a waste incineration fly ash sample;S2, preparing a leaching agent; S3, adding the sample prepared in the step S1 into the leaching agent prepared in the step S2 to prepare a leaching solution; S4, preparing a bacterial culture solution; S5, culturing the bacteria and evaluating the activity of the bacteria; S6, if the bacterial activity in the step S5 is qualified after being detected, further preparing a cell culture solution, andif the bacterial activity in the step S5 is unqualified after being detected, performing comet assay and western blot detection; S7, culturing cells; S8, taking the cells cultured in the step S7 formulti-cytotoxicity test, and evaluating the cell activity; S9, if the cell activity in the step S8 is detected to be qualified, ending the test, and if the cell activity is detected to be unqualified,performing comet assay; and S10, performing western blot analysis by the cells obtained in the step S7. According to the method, the toxic reaction of bacteria and biological cells to the leaching solution is directly utilized, and the method can be used for scientifically evaluating the toxicity detection of the waste incineration fly ash.
Owner:SICHUAN UNIV

Direct exposure in-vitro toxicity test method for electronic cigarette aerosol

PendingCN109988809AReflect biological effectsEvaluate damage effectsMicrobiological testing/measurementDiagnosticsInflammatory factorsElectronic cigarette
The invention provides a direct exposure in-vitro toxicity test method for electronic cigarette aerosol. The method is characterized in that testing of various cytotoxic terminal points and detectionof release levels of various inflammatory factors can be carried out, and the in-vitro toxicity effect of the electronic cigarette aerosol is reflected more comprehensively. The method specifically comprises the following steps of generation of the electronic cigarette aerosol, direct exposure of cells, testing of cytoxicity and detection of the inflammatory factors. According to the method, an in-vitro toxicity determination method of the electronic cigarette aerosol is established, and an in-vitro cell direct exposure experiment of the electronic cigarette aerosol, testing of the cytotoxic terminal points and the detection of the release levels of the inflammatory factors are integrated. After one-time exposure, the testing of the cytotoxic terminal points can be carried out on the cells, the detection of the inflammatory factors can be carried out on a cell supernatant, the evaluated toxic terminal points are numerous and efficient, the flux is high, and the in-vitro toxicity effectof the electronic cigarette aerosol can be represented comprehensively from multiple aspects.
Owner:ZHENGZHOU TOBACCO RES INST OF CNTC

Preparation method for TIA yeast peptide fermentation product filtrate and function application thereof in skin-whitening and freckle-removing

The invention discloses a preparation method for TIA yeast peptide fermentation product filtrate and a function application thereof in skin-whitening and freckle-removing. The preparation method comprises the following steps: S1, carefully selecting rice, washing for 1-2 times by using deionized water, and soaking for 6-12 hours in the room temperature; S2, crushing the soaked rice by using a crushing machine, adding distilled water and stirring until the homogenate, saccharifying for 2-12 hours, and cooling to 25-30 DEG C; S3, using pseudomonas saccharomycetes screened out by the amplification, enabling the bacteria density to be 0.5-2.5 OD, for the future fermentation adding and using; and S4, adding the saccharified rice homogenate to a culture medium. The preparation method is capableof performing the saccharomycetes fermentation by using the food material rice and vegetable edible fat and oil. The obtained wall-broken filtrate is safe completely without any external stimulation,and a cytotoxicity test shows the zero. The raw material obtained by using the preparation method can be used for preparing skin-whitening freckle-removing drugs or cosmetics, the cytotoxicity is zero, the raw material is safe and effective without the stimulation, good in stability, and is capable of avoiding the defects that a chemical whitening agent and a plant extractant can injure and stimulate a human body while used for whitening the skin, and the stability is bad.
Owner:重庆雅素生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products